A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor
Clinical trial NCT00796445 · TERMINATED
Trial details
- NCT number
- NCT00796445
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2016-01-27
- Enrollment
- 1351
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.